U.K. Canine Atopic Dermatitis Market Size & Outlook
The canine atopic dermatitis market in the UK is expected to reach a projected revenue of US$ 496.6 million by 2030. A compound annual growth rate of 10.1% is expected of the UK canine atopic dermatitis market from 2025 to 2030.
- Animal Health
- Animal Pharmaceuticals & Biotechnology
- Canine Atopic Dermatitis Market Outlook
- Animal Pharmaceuticals & Biotechnology
Revenue, 2024 (US$M)
$282.2
Forecast, 2030 (US$M)
$496.6
CAGR, 2025 - 2030
10.1%
Report Coverage
UK
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the canine atopic dermatitis market
Every figure cited from GVR research
UK canine atopic dermatitis market highlights
- The UK canine atopic dermatitis market generated a revenue of USD 282.2 million in 2024 and is expected to reach USD 496.6 million by 2030.
- The UK market is expected to grow at a CAGR of 10.1% from 2025 to 2030.
- In terms of segment, glucocorticoids was the largest revenue generating product in 2024.
- MAbs is the most lucrative product segment registering the fastest growth during the forecast period.
Canine atopic dermatitis market data book summary
| Market revenue in 2024 | USD 282.2 million |
| Market revenue in 2030 | USD 496.6 million |
| Growth rate | 10.1% (CAGR from 2025 to 2030) |
| Largest segment | Glucocorticoids |
| Fastest growing segment | MAbs |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Glucocorticoids, Antihistamines, Immunosuppressants, MAbs |
| Key market players worldwide | Zoetis Inc Class A, Merck & Co., Inc., Elanco, Boehringer Ingelheim International GmbH, Virbac SA, Vetoquinol SA, Biofelix Pharma Group, Dechra, Toray Industries Inc, Bioiberica, CEVA Inc, Bimeda |
Other key industry trends
- In terms of revenue, UK accounted for 7.3% of the global canine atopic dermatitis market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK canine atopic dermatitis market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 461.1 million by 2030.
No credit card required*
Publish Date: Nov 10, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Canine Atopic Dermatitis Market Scope
Canine Atopic Dermatitis Market segmentation & scope
Canine Atopic Dermatitis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Zoetis Inc Class A | View profile | 14,100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | www.zoetis.com |
| Virbac SA | View profile | 5,400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | www.virbac.com |
| CEVA Inc | View profile | 424 | 15245 Shady Grove Road, Suite 400, Rockville, MD, United States, 20850 | www.ceva-dsp.com |
| Toray Industries Inc | View profile | 48,682 | Nihonbashi Mitsui Tower 2-1-1, Nihonbashi Muromach, Chuo-ku, Tokyo, Japan, 103-8666 | www.toray.co.jp |
| Vetoquinol SA | View profile | 2,483 | Magny-Vernois, BP 189, Lure cedex, France, 70204 | www.vetoquinol.com |
| Bimeda | View profile | 1001-5000 | Dublin, Dublin, Ireland, Europe | www.bimeda.com/ |
| Bioiberica | View profile | 251-500 | Barcelona, Catalonia, Spain, Europe | www.bioiberica.com/ |
| Elanco | View profile | 10001+ | Greenfield, Indiana, United States, North America | www.elanco.com |
| Merck & Co., Inc. | View profile | - | - | - |
| Boehringer Ingelheim International GmbH | View profile | - | - | - |
U.K. Canine Atopic Dermatitis Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Canine Atopic Dermatitis Market Outlook will help companies and investors design strategic landscapes.
Glucocorticoids was the largest segment with a revenue share of 41.6% in 2024.
Horizon Databook has segmented the U.K. canine atopic dermatitis market based on glucocorticoids, antihistamines, immunosuppressants, mabs covering the revenue growth of each sub-segment from 2018 to 2030.
- U.K. Canine Atopic Dermatitis Market Product Outlook (Revenue, USD Million , 2018-2030)
- Glucocorticoids
- Antihistamines
- Immunosuppressants
- MAbs
- Others
- U.K. Canine Atopic Dermatitis Market Type Outlook (Revenue, USD Million , 2018-2030)
- Prescription
- OTC
- U.K. Canine Atopic Dermatitis Market Dog Breed Outlook (Revenue, USD Million , 2018-2030)
- German Shephard
- Terriers
- Retrievers
- Other Breeds
- U.K. Canine Atopic Dermatitis Market Mode of Administration Outlook (Revenue, USD Million , 2018-2030)
- Oral
- Topical
- Injectable
- U.K. Canine Atopic Dermatitis Market Indication Outlook (Revenue, USD Million , 2018-2030)
- Ectoparasites
- Food Allergy
- Allergic Skin Infections
- Others
- U.K. Canine Atopic Dermatitis Market Distribution Channel Outlook (Revenue, USD Million , 2018-2030)
- Veterinary Hospitals/Clinics
- Retail
- E-Commerce
Reasons to subscribe to Canine Atopic Dermatitis Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canine Atopic Dermatitis Market Outlook databook
- Our clientele includes a mix of Canine Atopic Dermatitis Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Canine Atopic Dermatitis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Canine Atopic Dermatitis Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
U.K. Canine Atopic Dermatitis Market, 2018-2030 (US$M)
UK canine atopic dermatitis market statistics, by product, 2018-2030 (US$M)
